Protests in US over high pricing of Novartis' anti-cancer drug Glivec - The Economic Times: "MUMBAI: Health activists and cancer patients in the US have pounced on Swiss drug multinational Novartis for the high price of its famous, multi-billion dollar anti-cancer drug Glivec, a development which challenges pharma MNCs' claims of cheap access and affordability for patented drugs.
Such protests, which began first in Europe, and have now spread to the US, could make it more difficult for pharma MNCs in developing countries to convince sceptical governments and public to provide protection in the form of patents, analysts and health activists say."
'via Blog this'
Tuesday, May 15, 2012
What is the price of getting treatment, the free market way?
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment